| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.480 | 9.983 | 9.507 | 9.841 | 9.229 | 16.943 | 19.565 | 18.862 | 21.635 | 24.644 |
| Total Income - EUR | 10.481 | 9.984 | 9.508 | 9.843 | 9.230 | 16.944 | 21.522 | 18.863 | 21.638 | 29.772 |
| Total Expenses - EUR | 7.901 | 11.117 | 10.628 | 9.305 | 8.842 | 9.747 | 16.157 | 14.734 | 19.227 | 28.847 |
| Gross Profit/Loss - EUR | 2.580 | -1.134 | -1.120 | 538 | 388 | 7.197 | 5.365 | 4.129 | 2.411 | 926 |
| Net Profit/Loss - EUR | 2.266 | -1.433 | -1.405 | 243 | 111 | 6.712 | 4.848 | 3.763 | 2.222 | 290 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Proapt Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 766 | 498 | 1.057 | 1.390 | 1.066 | 1.417 | 3.677 | 3.978 | 3.704 | 51.205 |
| Current Assets | 15.305 | 9.746 | 7.129 | 6.894 | 7.162 | 9.320 | 5.335 | 9.220 | 10.369 | 6.325 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 413 | 282 | 542 | 231 | 227 | 222 | 66 | 303 | 172 | -12 |
| Cash | 14.892 | 9.464 | 6.587 | 6.663 | 6.935 | 9.098 | 5.270 | 8.917 | 10.197 | 6.337 |
| Shareholders Funds | 15.660 | 9.614 | 8.046 | 8.141 | 8.094 | 8.125 | 8.538 | 12.327 | 12.315 | 12.536 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 410 | 630 | 140 | 142 | 133 | 611 | 475 | 870 | 1.758 | 45.916 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 2.001 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Proapt Medica Srl